Want to see AU:LDX full AI Analyst Report?

Lumos Diagnostics Holdings Ltd. (LDX) Price & Analysis

28 Followers

LDX Stock Chart & Stats

AU$0.32

AU$0.00(0.00%)

At close: Jan 09 4:00 PM EST

AU$0.32

AU$0.00(0.00%)

Day’s Range― - ―

52-Week RangeAU$0.03 - AU$0.33

Previous CloseN/A

Volume213.94K

Average Volume (3M)5.63M

Market Cap

AU$85.00M

Enterprise ValueAU$67.83M

Total Cash (Recent Filing)AU$3.00M

Total Debt (Recent Filing)AU$11.85M

Price to Earnings (P/E)―

Beta1.93

Next Earnings

Sep 01, 2026

EPS EstimateN/A

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)-0.01

Shares Outstanding944,389,160

10 Day Avg. Volume3,659,446

30 Day Avg. Volume5,628,467

Financial Highlights & Ratios

PEG Ratio0.04

Price to Book (P/B)1.96

Price to Sales (P/S)0.97

P/FCF Ratio-1.29

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

AU$0.08

Price Target Upside-75.00% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)>-0.01

Revenue Forecast (FY)AU$35.59M

Bulls Say, Bears Say

Bulls Say

Large Exclusive PHASE U.S. Distribution DealA contractual minimum USD 317m over six years materially increases multi-year revenue visibility and de-risks U.S. commercialization by outsourcing distribution to an established partner. This creates a durable sales channel and revenue backlog that supports scale-up and planning over the medium term.

Medicare/MAC Reimbursement SecuredCMS reimbursement at USD 41.38 per test materially improves recurring per-test economics and lowers adoption friction for physician offices and clinics. Durable coverage supports sustained unit demand, makes sales conversations easier, and underpins a recurring consumables revenue stream over multiple years.

Improving Cash And Profitability TrajectoryTurnaround in operating cash flow and a materially smaller adjusted EBITDA loss indicate operational leverage beginning to emerge. Consistent positive OCF and shrinking losses, if sustained, improve financial flexibility, reduce future financing needs, and support reinvestment for commercial scale over the next several quarters.

Bears Say

Commercial Upside Contingent On CLIA WaiverThe CLIA waiver is a structural gating item: without it, physician-office adoption and the PHASE distribution ramp are constrained. This conditionality means the material revenue stream from the PHASE contract and resultant margin/cash benefits remain speculative until regulatory approval is secured.

High Leverage And Weak Balance SheetElevated leverage reduces financial flexibility and increases refinancing and covenant risk when scaling commercial operations. With limited equity buffer and negative returns, the balance sheet constrains the company’s ability to fund manufacturing scale or absorb setbacks without additional external financing.

Declining Revenue And Persistent Losses HistoricallyA multi-period revenue decline and sustained negative margins indicate the business has not yet achieved self-sustaining growth. Continued reliance on nondilutive funding and project timing (services/IP variability) means product sales must scale materially to offset structural losses and deliver durable free cash flow.

Lumos Diagnostics Holdings Ltd. News

Lumos Diagnostics Reports Lapse of 43,000 Performance Rights

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an announcement. Lumos Diagnostics Holdings Ltd. has notified the...

2d ago

LDX

Lumos Diagnostics Shuts Shareholder Loan as Capital Raise Leaves It Debt-Free

The latest update is out from Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ). Lumos Diagnostics has closed its...

14d ago

LDX

Lumos Diagnostics Secures A$709,837 R&D Tax Rebate to Advance Point-of-Care Platforms

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) just unveiled an update. Lumos Diagnostics has received a cash refund...

17d ago

LDX

Lumos Diagnostics Director Sam Lanyon Increases Shareholding via On‑Market Purchase

An announcement from Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) is now available. Lumos Diagnostics has disclosed a...

21d ago

LDX

Lumos Diagnostics Seeks ASX Quotation for 15.2 Million New Shares

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an update. Lumos Diagnostics Holdings Limited has applied to...

24d ago

LDX

Lumos Diagnostics Director Catherine Robson Increases Indirect Shareholding

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has provided an update. Lumos Diagnostics Holdings Ltd. disclosed a change...

27d ago

LDX

Lumos Diagnostics Updates Director Doug Ward’s Expanded Equity Holding

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has provided an update. Lumos Diagnostics Holdings Ltd. has disclosed a...

1M ago

LDX

Lumos ramps up U.S. rollout of FebriDx ahead of investor briefing

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has issued an announcement. Lumos Diagnostics is expanding the U.S. rollout...

1M ago

LDX

Lumos Secures BARDA Milestone as FebriDx CLIA Waiver Unlocks US$1bn Market

An announcement from Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) is now available. Lumos Diagnostics has received a...

2M ago

LDX

Lumos Director Catherine Robson Increases Indirect Shareholding via Purchases and Share Plan

Lumos Diagnostics Holdings Ltd. ( ($AU:LDX) ) has shared an update. Lumos Diagnostics Holdings Ltd. has disclosed a...

3M ago

LDX

LDX FAQ

What was Lumos Diagnostics Holdings Ltd.’s price range in the past 12 months?

Lumos Diagnostics Holdings Ltd. lowest share price was AU$0.03 and its highest was AU$0.33 in the past 12 months.

What is Lumos Diagnostics Holdings Ltd.’s market cap?

Lumos Diagnostics Holdings Ltd.’s market cap is AU$85.00M.

When is Lumos Diagnostics Holdings Ltd.’s upcoming earnings report date?

Lumos Diagnostics Holdings Ltd.’s upcoming earnings report date is Sep 01, 2026 which is in 47 days.

How were Lumos Diagnostics Holdings Ltd.’s earnings last quarter?

Lumos Diagnostics Holdings Ltd. released its earnings results on Feb 26, 2026. The company reported -AU$0.009 earnings per share for the quarter, missing the consensus estimate of N/A by N/A.

Is Lumos Diagnostics Holdings Ltd. overvalued?

According to Wall Street analysts Lumos Diagnostics Holdings Ltd.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does Lumos Diagnostics Holdings Ltd. pay dividends?

Lumos Diagnostics Holdings Ltd. does not currently pay dividends.

What is Lumos Diagnostics Holdings Ltd.’s EPS estimate?

Lumos Diagnostics Holdings Ltd.’s EPS estimate for its next earnings report is not yet available.

How many shares outstanding does Lumos Diagnostics Holdings Ltd. have?

Lumos Diagnostics Holdings Ltd. has 944,389,160 shares outstanding.

What happened to Lumos Diagnostics Holdings Ltd.’s price movement after its last earnings report?

Lumos Diagnostics Holdings Ltd. reported an EPS of -AU$0.009 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 7.843%.

Which hedge fund is a major shareholder of Lumos Diagnostics Holdings Ltd.?

Currently, no hedge funds are holding shares in AU:LDX

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

Lumos Diagnostics Holdings Ltd. Stock Smart Score

Outperform

Fundamentals

Return on Equity

-164.12%

Trailing 12-Months

Asset Growth

-26.05%

Trailing 12-Months

Top Smart Score Stocks >

Company Description

Lumos Diagnostics Holdings Ltd.

Lumos Diagnostics Holdings Limited develops, manufactures, and commercializes point-of-care diagnostic products for diagnosis and management of infectious diseases in the United States. The company’s products include FebriDx, a point-of-care diagnostic test for detecting and differentiating viral and bacterial respiratory infections; and ViraDx, a three-in-one point-of-care test for influenza A, influenza B, and COVID-19. It also provides assay development and manufacturing services for point-of-care tests and proprietary digital reader platforms. Lumos Diagnostics Holdings Limited was incorporated in 2018 and is based in Carlsbad, California.

Lumos Diagnostics Holdings Ltd. (LDX) Earnings & Revenues

Historic Earnings Reports

LDX Stock 12 Month Forecast

Average Price Target

AU$0.08

▼(-75.00% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"0":"AU$0","1":"AU$1","-1":"-AU$1","-0.5":"-AU$0.5","0.5":"AU$0.5"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":0.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">AU$0.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">AU$0.08</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":0.08,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">AU$0.08</span>\n  </div></div>","useHTML":true}}],"tickPositions":[-1,-0.5,0,0.5,1],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Oct<br/>2025","6":"Jan<br/>2026","9":"Apr<br/>2026","12":"Jul<br/>2026","25":"Jul<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.105,0.10307692307692308,0.10115384615384615,0.09923076923076923,0.0973076923076923,0.09538461538461539,0.09346153846153846,0.09153846153846154,0.08961538461538461,0.0876923076923077,0.08576923076923076,0.08384615384615385,0.08192307692307693,{"y":0.08,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.105,0.10307692307692308,0.10115384615384615,0.09923076923076923,0.0973076923076923,0.09538461538461539,0.09346153846153846,0.09153846153846154,0.08961538461538461,0.0876923076923077,0.08576923076923076,0.08384615384615385,0.08192307692307693,{"y":0.08,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,0.105,0.10307692307692308,0.10115384615384615,0.09923076923076923,0.0973076923076923,0.09538461538461539,0.09346153846153846,0.09153846153846154,0.08961538461538461,0.0876923076923077,0.08576923076923076,0.08384615384615385,0.08192307692307693,{"y":0.08,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":0.03,"date":1751328000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.08,"date":1754006400000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.12,"date":1756684800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.14,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.2,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.2,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.32,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.23,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.265,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.235,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.17,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.11,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":0.105,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >